Samrat Pharmachem informs about change in management

16 Jul 2025 Evaluate
Samrat Pharmachem has informed that the Board of Directors of the Company at its meeting held today Wednesday, July 16, 2025, have approved the appointment of Piyush Gangji Dharod (DIN: 11119391) as Non-Executive Independent Directors of the Company (Additional Director) for a term of 5 (five) consecutive years each with effect from July 16, 2025, subject to the approval of the shareholders at the forthcoming 33rd AGM. Disclosure as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 is enclosed herewith as Annexure A. Piyush Gangji Dharod has confirmed that he meets the criteria of ‘Independence’ under the provisions of the Companies Act, 2013 and the SEBI (LODR) Regulations, 2015. Further, Piyush Gangji Dharod is not debarred from holding the office of a Director by virtue of any order passed by the Securities and Exchange Board of India or any other such authority and is not related to any of the Directors of the Company. The meeting of the Board commenced at 11.00 am and concluded at 1.00 pm.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

253.30 1.00 (0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×